Kirk Cryer

Title: Kirk Cryer: Innovator in Pharmaceutical Analysis and Polypeptide Cleavage

Introduction

Kirk Cryer is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of pharmaceutical analysis and polypeptide cleavage. With a total of 2 patents, his work has advanced the understanding and application of active pharmaceutical ingredients.

Latest Patents

Cryer’s latest patents include a method for the analysis and quantification of pancreatin active pharmaceutical agents. This innovative RP-HPLC method allows for the separation, identification, and quantification of multiple proteins in pancreatin active pharmaceutical ingredient samples. Additionally, he has developed a palladium-promoted hydrolytic polypeptide cleavage process. This invention selectively cleaves the polypeptide at a Cys-His cleavage site by solubilizing the polypeptide in a reaction mixture comprised of a palladium promoter dissolved in high-concentration formic acid.

Career Highlights

Throughout his career, Kirk Cryer has worked with various companies, including Scientific Protein Laboratories, LLC and Restoragen, Inc. His expertise in pharmaceutical sciences has made him a valuable asset in these organizations.

Collaborations

Cryer has collaborated with notable coworkers such as Rachel W Wezeman and Lin Rao. Their combined efforts have contributed to advancements in their respective fields.

Conclusion

Kirk Cryer is a distinguished inventor whose work in pharmaceutical analysis and polypeptide cleavage has made a lasting impact. His innovative patents and collaborations highlight his commitment to advancing science and technology.